Galapagos | GLPG - Equity Capital And Reserves

Stock Price
29.06
Daily Change
-0.10 -0.34%
Monthly
6.45%
Yearly
32.94%
Q1 Forecast
27.75

Galapagos reported EUR2.45B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
argenx SE USD 6.1B 597.47M Jun/2025
AstraZeneca USD 45.89B 1.17B Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Genmab DKK 5.3B 6M Jun/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
GlaxoSmithKline GBP 16.15B 1.79B Sep/2025
GRIFOLS EUR 5.18B 2.42B Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Incyte USD 4.65B 480.29M Sep/2025
Merck EUR 28.94B 677M Sep/2025
Neurocrine Biosciences USD 3B 309.3M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.03B 1.08B Dec/2024
Vertex Pharmaceuticals USD 17.32B 143.4M Sep/2025